Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 129,934 shares at $9.21 ($1.2M) on 2018-06-25, disclosed to the SEC on 2018-06-27.
Open-market sale of $1.2M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.21 | 26,752 | $246K | 20.7% |
| 2 | $9.21 | 26,752 | $246K | 20.7% |
| 3 | $9.19 | 21,224 | $195K | 16.4% |
| 4 | $9.19 | 21,224 | $195K | 16.4% |
| 5 | $9.03 | 16,991 | $153K | 12.9% |
| 6 | $9.03 | 16,991 |
| $153K |
| 12.9% |
| Total | $9.16 avg | 129,934 | $1.2M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |